Free Shipping Worldwide. Please expect up to 3-4 weeks shipping due to COVID supply chain delays for PDCare.

Research

Here are some top research studies our products are developed upon.

BMC NEUROLOGY

Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study.

More Research Supporting Light Therapy

"PBM was shown to be a safe and potentially effective treatment. Improvements were maintained for as long as treatment continued, for up to one year in a neurodegenerative disease where decline is typically expected." - BMC Neurology

How does light therapy offer neurological protection in Parkinson's disease? - NCBI

Treating the microbiome to affect changes in Parkinson’s patients. - Science Direct

Michael R Hamblin, 19 May 2017, Mechanisms and Applications of the Anti-inflammatory effects of Photobiomodulation - AIMS Biophysics Journal

Strong evidence identifying inhibition of nerve function as a mechanism for the clinical application of PBM in pain and anesthesia. - Mary Ann Liebert, Inc

Remote Photobiomodulation Treatment for the Clinical Signs of Parkinson's
Disease: A Case Series Conducted During Lockdown - Pub Med

Why Light Therapy?

Light therapy is the non-thermal delivery of waves of light energy with a therapeutic benefit. SYMBYX’s medical-grade lasers are easy to use at home and ARTG/CE listed for reduction in many symptoms.

View More